PBM — Psyence Biomedical Balance Sheet
0.000.00%
Last trade - 00:00- $1.96m
- $8.89m
Annual balance sheet for Psyence Biomedical, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | fx Final | Final | Final |
| Cash | |||
| Cash and Short Term Investments | 1.75 | 1.33 | 0.733 |
| Net Total Receivables | 0.039 | 0.149 | 0.042 |
| Prepaid Expenses | |||
| Total Other Current Assets | |||
| Total Current Assets | 1.83 | 1.59 | 1.13 |
| Gross Property, Plant And Equipment | |||
| Accumulated Depreciation | |||
| Net Property, Plant And Equipment | — | 0 | 0.005 |
| Total Assets | 1.83 | 1.59 | 1.13 |
| Accounts Payable | |||
| Accrued Expenses | |||
| Notes Payable / Short Term Debt | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | 0.132 | 1.79 | 12.1 |
| Total Long Term Debt | |||
| Total Debt | |||
| Total Liabilities | 0.132 | 1.79 | 12.1 |
| Common Stock | |||
| Retained Earnings (Accumulated Deficit) | |||
| Other Equity | |||
| Total Equity | 1.7 | -0.2 | -11 |
| Total Liabilities & Shareholders' Equity | 1.83 | 1.59 | 1.13 |
| Total Common Shares Outstanding |